P

Priovant Therapeutics Tech Stack

Clinical-stage biotech developing targeted autoimmune disease therapies

Biotechnology Research Durham, NC 51–200 employees Privately Held

Priovant is a clinical-stage biotech company in Durham, NC with 51–200 employees, actively scaling its healthcare and support teams (57 open roles, 46 posted in the last 30 days). The hiring velocity and project focus—launch readiness, regulatory coordination, patient access optimization, and time-to-therapy acceleration—signal transition from R&D into clinical development and commercial preparation. Pain-point clustering around therapy delays, coverage barriers, and administrative bottlenecks reveals operational friction typical of biotech moving toward market launch.

Tech Stack 10 technologies

Core Stackmonday.com Monday.com NetSuite Excel PowerPoint CRM BioRender GraphPad Prism EndNote Coupa

What Priovant Therapeutics Is Building

◆Challenges

Coverage challenges
Reducing administrative delays
Access to therapy
Minimizing delays in patient care
Minimizing therapy delays
Launch readiness
Reducing therapy delays
Accelerating time-to-therapy
Access resolution
Transition from r&d accounting to commercial inventory

▲Active Projects

Launch readiness
Time-to-therapy acceleration
Epa platform navigation
Patient access and affordability challenges
Patient access optimization
Brepocitinib clinical development
Coordinate regulatory documentation review
Rare disease launch initiatives
Board decks
Scientific presentations

Hiring Activity

Accelerating55 roles · 45 in 30d

Department

Healthcare

30

Support

18

Finance

2

Ops

2

Manufacturing

1

Marketing

1

Quality

1

Research

1

Seniority

Mid

41

Director

6

Manager

5

Senior

3

Junior

2

Company intelligence

Find more companies like Priovant Therapeutics by tech stack, pain points and active projects

Get started free

About Priovant Therapeutics

Priovant Therapeutics develops targeted therapies for severe autoimmune diseases, focusing on patient populations underserved by existing treatments. The company is clinical-stage, with active development programs including brepocitinib. Operations span regulatory coordination, patient access and affordability strategy, rare disease launch planning, and the transition from R&D accounting to commercial inventory management. The tech stack—Excel, PowerPoint, monday.com, BioRender, GraphPad Prism, NetSuite, and Coupa—reflects a biotech infrastructure balancing scientific collaboration, project management, and financial operations. Headquartered in Durham, NC, the company is privately held and hiring exclusively in the United States.

HeadquartersDurham, NC

Company Size51–200 employees

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Priovant Therapeutics use?

Excel, PowerPoint, monday.com for project management, BioRender and GraphPad Prism for scientific work, EndNote for literature, and NetSuite and Coupa for finance and operations.

What is Priovant Therapeutics working on?

Launch readiness, brepocitinib clinical development, regulatory documentation coordination, patient access optimization, and rare disease launch initiatives. Also managing transition from R&D to commercial accounting and inventory.